Horm Metab Res 2022; 54(04): 212-219
DOI: 10.1055/a-1769-5032
Review

Recent Advances of LncRNA H19 in Diabetes

Ye Bi
1   Department of Geriatrics, Shandong First Medical University, Jinan, China
,
Yao Wang
2   Shandong Institute of Endocrine and Metabolic Diseases, Medical University, Jinan, China
,
1   Department of Geriatrics, Shandong First Medical University, Jinan, China
› Author Affiliations

Funding Information This work was funded by Science and Technology Development Projects of Jinan City (201805062), and Natural Science Foundation of China (81800753).
Preview

Abstract

Diabetes mellitus (DM) causes damage to major organs, including the heart, liver, brain, kidneys, eyes, and blood vessels, threatening the health of the individuals. Emerging evidence has demonstrated that lncRNAs has important functions in the pathogenesis of human diseases, such as cancers, neurodegenerative diseases, cardiac fibroblast phenotypes, hypertension, heart failure, atherosclerosis and diabetes. Recently, H19, a lncRNA, has been reported to shown to participate in the regulatory process of muscle differentiation, glucose metabolism, and tumor metastasis, as well as endometrial development. However, the roles of H19 in DM were still not completely understood. This review was conducted to summarize the functions of H19 in diabetes and discuss the challenges and possible strategies of H19 in DM.



Publication History

Received: 07 December 2021

Accepted after revision: 26 January 2022

Article published online:
12 April 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag
Rüdigerstraße 14,70469 Stuttgart, Germany